Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polidocanol versus lauromacrogol ultrasound-guided sclerotherapy for ovarian endometrioma
ChiCTR2300069368Phase 4Recruiting
- Sponsor
- The First Medical Center of Chinese PLA General Hospital
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of 10XB101 and polidocanol in endometrioma (2 arms), sponsored by The First Medical Center of Chinese PLA General Hospital. Primary endpoint: Reduction rate of cyst volume. Started Mar 2023; status: recruiting.
02
Drugs
10XB101polidocanol
03
Conditions
endometrioma
Beyond the preview
Go deeper on ChiCTR2300069368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300069368.